A platform for a bigger play
We recently assessed a healthcare compliance software platform as a potential investment target for our client - a mid-market PE firm. Our objectives were to establish the quality and coherence of the existing software, the effectiveness of version control across clients, and the capacity of the team for a wider 'platform' play.
These findings may be valuable for private equity investment directors evaluating similar opportunities in the healthcare sector.
Divergent technology stack
Our analysis revealed a divergent technology stack that, while fit-for-purpose today, has several issues that need to be addressed to ensure long-term success and scalability.
Consolidation opportunities
We identified elegant opportunities to consolidate the technology base and improve user experience. However, successful adoption will require flexibility from clients, necessitating a well-planned transition strategy.
Team capacity and capability
Evaluating the team's capacity and capability is crucial for a wider platform play. Our assessment provides valuable insights into the team's strengths and areas for improvement, enabling better decision-making and resource allocation.
Give diligence its due
These insights emphasize the importance of thorough technology due diligence when evaluating healthcare compliance software platforms, both in terms of the technology itself and the team behind it.
If you've encountered similar challenges or have insights to share, please feel free to reach out.
Assessing a Product Impact Scoring Platform
More Insights
Scalability and Technology Insights from Our Due Diligence.